|Podcasts|February 23, 2021

Nanoscale IR Spectroscopy with Dr. Curtis Marcott

Author(s)Bruker

Background/Introduction to Nanoscale Infrared Spectroscopy/AFM-IR Life Science Applications of Nanoscale IR Some Recent NanoIR Cells and Tissue Research

Related to this article

Electromagnetic electric field background | Image Credit: © pixel - stock.adobe.com.
In this clip from our SciX interview with Siddhartha Das, he describes his team’s “eureka moment”: the discovery that the ion distribution inside a polymer layer shapes how water moves under an electric field. He also explains why experimental confirmation is still years away.
2026 SciX Conference Summary ©   Bos Amico -chronicles-stock.adobe.com
SciX 2026, the annual conference presented by the Federation of Analytical Chemistry and Spectroscopy Societies (FACSS), ran October 4–9, 2026, at the Nugget Casino Resort in Sparks, Nevada. The program spanned atomic and molecular spectroscopy, mass spectrometry, chemometrics, and bioanalysis. This report follows the meeting day by day, from Monday's clinical Raman plenaries to Friday's closing talks, drawing on the online program and Spectroscopy coverage of award winners, highlighting efforts to move Raman, SERS, LIBS, and single-particle ICP-MS toward clinical, environmental, and field use.
Disco laser light seen from the side | Image Credit: © Soonios Pro - stock.adobe.com
At SciX, Alessandro De Giacomo explains how a 35-member international jury chose three papers: one on correct ICCD use and two applications using LIBS and LA-ICP-MS. He also explains what the selections say about the field.
2026 SciX Conference Innovation ©   Dilok -chronicles-stock.adobe.com
Four finalists for the FACSS Innovation Award presented on the afternoon of October 8, 2026, at SciX 2026. Their work spanned drone-mounted laser-induced breakdown spectroscopy (LIBS), a touch-and-sound virtual reality system for blind scientists, polarized infrared (IR) imaging of shape memory polymers, and an ultrasound-activated plasmonic nanoplatform aimed at Parkinson’s disease.